这是一篇来自已证抗体库的有关
人类 DCAF1的综述,是根据10篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合DCAF1 抗体。
DCAF1 同义词: RIP; VPRBP; DDB1- and CUL4-associated factor 1; HIV-1 Vpr-binding protein; Vpr (HIV-1) binding protein; Vpr-binding protein; protein VPRBP; serine/threonine-protein kinase VPRBP; vpr-interacting protein
Bethyl
兔 多克隆 | | Bethyl DCAF1抗体(Bethyl Laboratories, A301-887A)被用于被用于免疫印迹在人类样品上 (图 3a). Oncogene (2017) ncbi |
兔 多克隆 | - 免疫印迹; 人类; 图 s5b
- 免疫印迹; 小鼠; 图 4e
| Bethyl DCAF1抗体(Bethyll, A301-887A)被用于被用于免疫印迹在人类样品上 (图 s5b) 和 被用于免疫印迹在小鼠样品上 (图 4e). Nature (2016) ncbi |
兔 多克隆 | | Bethyl DCAF1抗体(Bethyl Laboratories, A301-888A)被用于被用于免疫印迹在人类样品上 (图 3). Sci Rep (2016) ncbi |
兔 多克隆 | | Bethyl DCAF1抗体(Bethyl Laboratories, A301-888A)被用于被用于免疫印迹在人类免疫缺陷病毒1样品上 (图 3). J Biol Chem (2015) ncbi |
兔 多克隆 | | Bethyl DCAF1抗体(Bethyl/Euromedex, A301-88A)被用于被用于免疫细胞化学在小鼠样品上浓度为1:3000. Cell (2014) ncbi |
兔 多克隆 | | Bethyl DCAF1抗体(Bethyl/Euromedex, A301-88A)被用于被用于免疫细胞化学在小鼠样品上浓度为1:3000. Cell (2014) ncbi |
武汉三鹰
兔 多克隆 | - 免疫印迹基因敲除验证; 人类; 1:2000; 图 s5b
- 免疫印迹基因敲除验证; 小鼠; 1:2000; 图 2c
- 免疫沉淀; 小鼠; 1:200; 图 6b
| 武汉三鹰 DCAF1抗体(Proteintech, 11612-1-AP)被用于被用于免疫印迹基因敲除验证在人类样品上浓度为1:2000 (图 s5b), 被用于免疫印迹基因敲除验证在小鼠样品上浓度为1:2000 (图 2c) 和 被用于免疫沉淀在小鼠样品上浓度为1:200 (图 6b). Nat Commun (2016) ncbi |
兔 多克隆 | - 免疫印迹; scFv; 1:1000; 图 3
- 免疫组化基因敲除验证; 小鼠; 1:200; 图 s1
- 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 3
| 武汉三鹰 DCAF1抗体(Proteintech, 11612-1-AP)被用于被用于免疫印迹在scFv样品上浓度为1:1000 (图 3), 被用于免疫组化基因敲除验证在小鼠样品上浓度为1:200 (图 s1) 和 被用于免疫印迹基因敲除验证在小鼠样品上浓度为1:1000 (图 3). Nat Commun (2015) ncbi |
兔 多克隆 | | 武汉三鹰 DCAF1抗体(Proteintech Group, 11612-1-AP)被用于被用于免疫细胞化学在人类样品上浓度为1:150. Cancer Cytopathol (2014) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(C-8) | | 圣克鲁斯生物技术 DCAF1抗体(Santa Cruz Biotechnology, sc-376850)被用于被用于免疫印迹在人类样品上 (图 4). Proc Natl Acad Sci U S A (2016) ncbi |
Novus Biologicals
兔 多克隆 | | Novus Biologicals DCAF1抗体(Novus, NBP1-05953)被用于被用于免疫印迹在人类样品上 (图 4e). Nature (2017) ncbi |
Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S,
et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ER?. Nature. 2017;541:541-545
pubmed 出版商
Matsuura K, Huang N, Cocce K, Zhang L, Kornbluth S. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin. Oncogene. 2017;36:1698-1706
pubmed 出版商
Wang D, Kon N, Lasso G, Jiang L, Leng W, Zhu W,
et al. Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature. 2016;538:118-122
pubmed 出版商
Romani B, Kamali Jamil R, Hamidi Fard M, Rahimi P, Momen S, Aghasadeghi M,
et al. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin. Sci Rep. 2016;6:31924
pubmed 出版商
Hrecka K, Hao C, Shun M, Kaur S, Swanson S, Florens L,
et al. HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins. Proc Natl Acad Sci U S A. 2016;113:E3921-30
pubmed 出版商
Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F,
et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307
pubmed 出版商
Yu C, Ji S, Sha Q, Sun Q, Fan H. CRL4-DCAF1 ubiquitin E3 ligase directs protein phosphatase 2A degradation to control oocyte meiotic maturation. Nat Commun. 2015;6:8017
pubmed 出版商
Romani B, Shaykh Baygloo N, Aghasadeghi M, Allahbakhshi E. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest. J Biol Chem. 2015;290:17380-9
pubmed 出版商
Liu Y, Jiang Y, Wang B, Hao J, Shang L, Zhang T,
et al. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens. Cancer Cytopathol. 2014;122:833-41
pubmed 出版商
Laguette N, Brégnard C, Hue P, Basbous J, Yatim A, Larroque M,
et al. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell. 2014;156:134-45
pubmed 出版商